SuspendedPhase 4ketamine
Ketamine for Sedation in Severe Traumatic Brain Injury
Sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine
NCT ID
NCT06429657
Target Enrollment
50 participants
Start Date
2024-09-23
Est. Completion
2027-06-30
About This Study
This protocol is for an open-label randomized trial evaluating the safety of using ketamine in combination with propofol for sedation versus the standard of care analgosedation in patients admitted to the intensive care unit with severe traumatic brain injury.
Conditions Studied
Interventions
- •Ketamine with propofol
- •Standard of Care propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Adults 18-65 years of age * Severe traumatic brain injury (TBI), with a Glasgow Coma Scale (GCS) ≤ 8, requiring intracranial monitoring * Placement of intracranial pressure monitor * Receiving treatment in an intensive care unit (ICU) Exclusion Criteria: * Significant cardiovascular disease with recent coronary intervention * Pregnancy * Prisoners * Known allergy to ketamine or propofol
Study Locations (1)
Brooke Army Medical Center
Fort Sam Houston, Texas, United States